News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Amazon Biotech Issues Shareholder Update of Corporate Developments
December 11, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, NY--(Marketwire - December 10, 2007) - Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2D) has released the following update to shareholders:
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
MORE ON THIS TOPIC
Lung cancer
ESMO 2026: Amgen’s Imdelltra slashes death risk by nearly 60% in small cell lung cancer
October 26, 2026
·
4 min read
·
Tristan Manalac
Ovarian cancer
Genmab’s ADC beats survival expectations in Phase 3 ovarian cancer trial
October 26, 2026
·
2 min read
·
Nick Paul Taylor
Insights
Australia’s clinical trial advantage gains ground amid U.S. uncertainty
October 26, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Autoimmune diseases
BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial
October 23, 2026
·
3 min read
·
Heather McKenzie
